Log In
BCIQ
Print this Print this
 

Avacopan (CCX168)

Also known as: C5aR inhibitor

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionSmall molecule complement receptor 5a (C5aR; CD88) inhibitor
Molecular Target Complement receptor 5a (CD88)
Mechanism of ActionComplement receptor 5a inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$600.0M

$60.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/10/2016

$600.0M

$60.0M

Undisclosed

Get a free BioCentury trial today